Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Hung-Yu Chan, MD, PhD
JCP
Letter to the Editor
Reply to The Emerging Role of Atypical Antipsychotics in the Treatment of Tardive Dyskinesia Induced by Other Atypical Antipsychotics
July 15, 2011
Hung-Yu Chan
,
Ching-Jui Chang
,
Susan S.-F. Gau
JCP
Letter to the Editor
Reply to Is There a Real Difference in Severity of Tardive Dyskinesia Between Risperidone and Olanzapine?
November 15, 2010
Hung-Yu Chan
,
Susan S.-F. Gau
JCP
Original Research
A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
April 20, 2010
Mei-Shu Lai
,
Hung-Yu Chan
,
Shu-Chuan Chiang
, et al
JCP
Original Research
Efficacy and Safety of Aripiprazole in the Acute Treatment of Schizophrenia in Chinese Patients With Risperidone as an Active Control: A Randomized Trial
January 15, 2007
Shih-Ku Lin
,
Tzung-Jeng Hwang
,
Hung-Yu Chan
, et al
